Related references
Note: Only part of the references are listed.Current concepts in the management of Helicobacter pylori infection:: the maastricht III consensus report
P. Malfertheiner et al.
GUT (2007)
Update on fluoroquinolone resistance in Helicobacter pylori:: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility
Vincent Cattoir et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Levofloxacin-vs. ranitidine bismuth citrate-containing therapy after H-pylori treatment failure
Javier P. Gisbert et al.
HELICOBACTER (2007)
The relationship between previous fluoroquinolone use and levofloxacin resistance in Helicobacter pylori infection
John J. Carothers et al.
CLINICAL INFECTIOUS DISEASES (2007)
Quinolone resistance in Helicobacter pylori isolates in Germany
Erik Glocker et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Third-line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures
J. P. Gisbert et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Prevalence and mechanisms of resistance to fluoroquinolones in Helicobacter pylori strains from patients living in Belgium
Pierre Bogaerts et al.
HELICOBACTER (2006)
Primary levofloxacin resistance and gyrA/B mutations among Helicobacter pylori in Japan
Hideyuki Miyachi et al.
HELICOBACTER (2006)
Role of the preliminary susceptibility testing for initial and after failed therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and esomeprazole
Leonardo Marzio et al.
HELICOBACTER (2006)
Comparison of primary and secondary antimicrobial minimum inhibitory concentrations for Helicobacter pylori isolated from Korean patients
Jung Mogg Kim et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection:: A meta-analysis
RJ Saad et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection
WM Wong et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Third-line rescue therapy with levofloxacin after two H-Pylori treatment failures
JP Gisbert et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
7-day triple therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and high-dose esomeprazole in patients with known antimicrobial sensitivity
D Antos et al.
HELICOBACTER (2006)
A study of 4-and 7-day triple therapy with rabeprazole, high-dose levofloxacin and tinidazole rescue treatment for Helicobacter pylori eradication
EG Giannini et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure
JP Gisbert et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Levofloxacin-versus metronidazole-based rescue therapy for H-pylori infection in Japan
Y Matsumoto et al.
DIGESTIVE AND LIVER DISEASE (2005)
Rescue therapy with levofloxacin after multiple H-pylori treatment failures
JP Gisbert
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Helicobacter pylori rescue therapy after failure of two eradication treatments
JP Gisbert et al.
HELICOBACTER (2005)
Seven versus ten days of rabeprazole triple therapy for Helicobacter pylori eradication:: A multicenter randomized trial
X Calvet et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
A 10-day levofloxacin-based triple therapy in patients who have failed two eradication courses
L Gatta et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
New once-daily, highly effective rescue triple therapy after multiple Helicobacter pylori treatment failures:: a pilot study
LGV Coelho et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
A 10-Day Levofloxacin-Based Therapy in Patients With Resistant Helicobacter pylori Infection: A Controlled Trial
Claudio Bilardi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2004)
The TETRA study: A prospective evaluation of Helicobacter pytori 'test-and-treat' strategy on 736 patients in clinical practice
JP Gisbert et al.
HELICOBACTER (2004)
Randomized study of different 'second-line' therapies for Helicobacter pylori infection after failure of the standard 'Maastricht triple therapy'
F Perri et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Levofloxacin based triple therapy as a second-line treatment after failure of Helicobacter pylori eradication with standard triple therapy
Y Watanabe et al.
DIGESTIVE AND LIVER DISEASE (2003)
Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment:: a randomized trial
EC Nista et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
A third-line levofloxacin-based rescue therapy for Helicobacter pylori eradication
A Zullo et al.
DIGESTIVE AND LIVER DISEASE (2003)
'Rescue' therapy with rifabutin after multiple Helicobacter pylori treatment failures
JP Gisbert et al.
HELICOBACTER (2003)
Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second-line treatment for Helicobacter pylori infection
WM Wong et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Risk factors for failure of Helicobacter pylori therapy - results of an individual data analysis of 2751 patients
N Broutet et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Levofloxacin - A review of its use in the treatment of bacterial infections in the United States
KF Croom et al.
DRUGS (2003)
Synergic effect of quinolone antibacterial agents and proton pump inhibitors on Helicobacter pylori
M Tanaka et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Helicobacter pylori 'rescue' regimen when proton pump inhibitor-based triple therapies fail
JP Gisbert et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
Helicobacter pylori therapy: First-line options and rescue regimen
JP Gisbert et al.
DIGESTIVE DISEASES (2001)
Features and trends in Helicobacter pylori antibiotic resistance in Lisbon area, Portugal (1990-1999)
J Cabrita et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
Susceptibility of Helicobacter pylori to mupirocin, oxazolidinones, quinupristin/dalfopristin and new quinolones
JEG Sánchez et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
Share Paper
